Supplementary Table 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 130KB, Clinicopathologic Characteristics in NSCLC Patients with FGFR, ALK, RET and ROS1 fusions.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361885485
